Gene · 2213
NIH grants2,625
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 2,625
Download this page as JSON| Grant | Title | FCGR2B papers | Newest fiscal year |
|---|---|---|---|
| K24AR063120 | Outcomes Research in Rheumatic Diseases | 1 | 2022 |
| P01AI062885 | Epithelial innate signaling in airway inflammation and remodeling | 1 | 2022 |
| P01CA210944 | Radiation and checkpoint blockade for cancer immune therapy | 1 | 2022 |
| P01CA217798 | Pancreatic Cancer Metastasis | 1 | 2022 |
| P01CA225622 | Experimental Therapy for Brain Tumors | 1 | 2022 |
| P01CA229100 | Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma | 1 | 2022 |
| P30DK079337 | UAB-UCSD O'Brien Center for Acute Kidney Injury Research | 1 | 2022 |
| P30DK081943 | University of Michigan O'Brien Kidney Translational Core Center | 1 | 2022 |
| P30GM127211 | Center of Research on Obesity and Cardiovascular Disease | 1 | 2022 |
| R00CA240896 | Mechanism and therapeutic potential of macrophage regulation in glioblastoma | 1 | 2022 |
| R01AG061796 | Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD | 1 | 2022 |
| R01AI051231 | Virologic Correlates of Heterosexual Transmission | 1 | 2022 |
| R01AI052116 | Spatiotemporal Control of T cell Synapse Stabilization and Signaling | 1 | 2022 |
| R01AI107731 | Molecular Basis of Flavivirus Cross-Neutralization by Human Antibodies | 1 | 2022 |
| R01AI125567 | FUNCTIONAL ANALYSIS OF PATHOGENIC AND PROTECTIVE PEANUT ALLERGEN-SPECIFIC HUMAN ANTIBODIES | 1 | 2022 |
| R01AI132738 | Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling | 1 | 2022 |
| R01AI132949 | Erythropoietin mediated immunoregulation in murine lupus nephritis | 1 | 2022 |
| R01AI134023 | B cell intrinsic interferon-beta regulates autoreactive B cell development | 1 | 2022 |
| R01AI134895 | Revisiting alginate paradigms | 1 | 2022 |
| R01AI137174 | Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD) | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/grants?page=39